European results in neutron therapy of malignant salivary gland tumors.

Andreas Krüll; R Schwarz; R Engenhart; P Huber; A Lessel; H Koppe; A Favre; N Breteau; T Auberger

European results in neutron therapy of malignant salivary gland tumors.

Standard

European results in neutron therapy of malignant salivary gland tumors. / Krüll, Andreas; Schwarz, R; Engenhart, R; Huber, P; Lessel, A; Koppe, H; Favre, A; Breteau, N; Auberger, T.

In: Bull Cancer Radiother, Vol. 83 Suppl, 1996.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Krüll, A, Schwarz, R, Engenhart, R, Huber, P, Lessel, A, Koppe, H, Favre, A, Breteau, N & Auberger, T 1996, 'European results in neutron therapy of malignant salivary gland tumors.', Bull Cancer Radiother, vol. 83 Suppl. <http://www.ncbi.nlm.nih.gov/pubmed/8949764?dopt=Citation>

APA

Krüll, A., Schwarz, R., Engenhart, R., Huber, P., Lessel, A., Koppe, H., Favre, A., Breteau, N., & Auberger, T. (1996). European results in neutron therapy of malignant salivary gland tumors. Bull Cancer Radiother, 83 Suppl. http://www.ncbi.nlm.nih.gov/pubmed/8949764?dopt=Citation

Vancouver

Krüll A, Schwarz R, Engenhart R, Huber P, Lessel A, Koppe H et al. European results in neutron therapy of malignant salivary gland tumors. Bull Cancer Radiother. 1996;83 Suppl.

Bibtex

@article{d13af14d91fd4a20ac83e0f653af7062,

title = "European results in neutron therapy of malignant salivary gland tumors.",

abstract = "In Europe to date, 501 patients with salivary gland tumors have been treated with neutrons alone or with combined modalities. The most common histological types are adenoid cystic carcinomas, mucoepidermoid carcinomas and malignant mixed tumors. The results of conventional radiotherapy are suboptimal in inoperable or incompletely resected salivary gland tumors and in recurrent disease. The pooled data of some international series for low linear energy transfer radiation show a local control of 28%. Especially in advanced tumors neutron therapy can improve local control and should be the treatment of choice. The clinical data from different therapy centers in Europe show local control of 67% in gross disease.",

keywords = "Humans, Europe, Prognosis, Survival Analysis, Follow-Up Studies, Combined Modality Therapy, Radiotherapy Dosage, Neoplasm Staging, Radiotherapy, High-Energy/*methods, Carcinoma, Adenoid Cystic/mortality/pathology/*radiotherapy, Carcinoma, Mucoepidermoid/mortality/pathology/*radiotherapy, *Fast Neutrons, Salivary Gland Neoplasms/mortality/pathology/*radiotherapy, Humans, Europe, Prognosis, Survival Analysis, Follow-Up Studies, Combined Modality Therapy, Radiotherapy Dosage, Neoplasm Staging, Radiotherapy, High-Energy/*methods, Carcinoma, Adenoid Cystic/mortality/pathology/*radiotherapy, Carcinoma, Mucoepidermoid/mortality/pathology/*radiotherapy, *Fast Neutrons, Salivary Gland Neoplasms/mortality/pathology/*radiotherapy",

author = "Andreas Kr{\"u}ll and R Schwarz and R Engenhart and P Huber and A Lessel and H Koppe and A Favre and N Breteau and T Auberger",

year = "1996",

language = "English",

volume = "83 Suppl",

}

RIS

TY - JOUR

T1 - European results in neutron therapy of malignant salivary gland tumors.

AU - Krüll, Andreas

AU - Schwarz, R

AU - Engenhart, R

AU - Huber, P

AU - Lessel, A

AU - Koppe, H

AU - Favre, A

AU - Breteau, N

AU - Auberger, T

PY - 1996

Y1 - 1996

N2 - In Europe to date, 501 patients with salivary gland tumors have been treated with neutrons alone or with combined modalities. The most common histological types are adenoid cystic carcinomas, mucoepidermoid carcinomas and malignant mixed tumors. The results of conventional radiotherapy are suboptimal in inoperable or incompletely resected salivary gland tumors and in recurrent disease. The pooled data of some international series for low linear energy transfer radiation show a local control of 28%. Especially in advanced tumors neutron therapy can improve local control and should be the treatment of choice. The clinical data from different therapy centers in Europe show local control of 67% in gross disease.

AB - In Europe to date, 501 patients with salivary gland tumors have been treated with neutrons alone or with combined modalities. The most common histological types are adenoid cystic carcinomas, mucoepidermoid carcinomas and malignant mixed tumors. The results of conventional radiotherapy are suboptimal in inoperable or incompletely resected salivary gland tumors and in recurrent disease. The pooled data of some international series for low linear energy transfer radiation show a local control of 28%. Especially in advanced tumors neutron therapy can improve local control and should be the treatment of choice. The clinical data from different therapy centers in Europe show local control of 67% in gross disease.

KW - Humans

KW - Europe

KW - Prognosis

KW - Survival Analysis

KW - Follow-Up Studies

KW - Combined Modality Therapy

KW - Radiotherapy Dosage

KW - Neoplasm Staging

KW - Radiotherapy, High-Energy/methods

KW - Carcinoma, Adenoid Cystic/mortality/pathology/radiotherapy

KW - Carcinoma, Mucoepidermoid/mortality/pathology/radiotherapy

KW - Fast Neutrons

KW - Salivary Gland Neoplasms/mortality/pathology/radiotherapy